Cargando…

Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study

INTRODUCTION: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The prevalence of hepatitis B (HBV) and C (HCV) in Russia was 7.6 and 5.4 per 100,000, respectively. The aim of this study was to assess the proportion of HCV and HBV infection among HCC patients, to evaluate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Makarova, Maria, Krettek, Alexandra, Valkov, Mikhail Y., Grjibovski, Andrej M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654160/
https://www.ncbi.nlm.nih.gov/pubmed/23687637
http://dx.doi.org/10.3402/ijch.v72i0.20282
_version_ 1782269498500317184
author Makarova, Maria
Krettek, Alexandra
Valkov, Mikhail Y.
Grjibovski, Andrej M.
author_facet Makarova, Maria
Krettek, Alexandra
Valkov, Mikhail Y.
Grjibovski, Andrej M.
author_sort Makarova, Maria
collection PubMed
description INTRODUCTION: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The prevalence of hepatitis B (HBV) and C (HCV) in Russia was 7.6 and 5.4 per 100,000, respectively. The aim of this study was to assess the proportion of HCV and HBV infection among HCC patients, to evaluate associations between HCV, HBV and stage of HCC and to compare survival of HCC patients by their HBV/HCV status in the Arkhangelsk region of northwest Russia. MATERIALS AND METHODS: A retrospective cohort study was conducted using data on all histologically confirmed HCC cases. Proportions of infected and non-infected HCC cases were calculated by Wilson's method. The associations between HBV, HCV and severity of HCC were assessed by Pearson's Chi-squared test. Survival data were presented using Kaplan–Meier curves and median survival. Survival time between the groups was compared using log-rank tests. Adjustment for potential confounders (sex, age groups, stage of HCC and cirrhosis stage by Child-Paquet scale) was performed using Cox regression. RESULTS: There were 583 histologically confirmed HCC cases. The viral status was registered in 311 of patients with pre-mortem diagnosis, where 124 or 39.9% (95% confidence interval (CI), 34.4–45.4) had HBV, 54 or 17.4% (95% CI, 13.5–21.9) had HCV and 16 or 5.1% (95% CI, 3.2–8.2) were infected with both HBV and HCV. The median survival rates of patients were 3 months (95% CI, 2.3–3.8), 3 months (95% CI, 2.0–3.9) and 1 month (95% CI, 0.0–0.6) for patients with HBV, HCV and HBV and HCV, respectively. For virus-free patients, it was 5 months (95% CI, 3.5–6.5), log-rank test=10.74, df=3, p=0.013. Crude Cox regression showed increased risk of death for HBV and HBV and HCV groups in comparison with virus-free patients, and not reaching the level of statistical significance for HCV. After adjustment, the hazard ratios (HRs) decreased to non-significant levels or even reversed, with only exception for the group of patients infected with both hepatitis viruses. CONCLUSIONS: We found that more than half of HCC patients were infected with HBV or HCV. The study did not reveal an association between viral status of HCC patients and stage of HCC. The viral hepatitis may have an impact on survival of HCC patients.
format Online
Article
Text
id pubmed-3654160
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-36541602013-05-17 Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study Makarova, Maria Krettek, Alexandra Valkov, Mikhail Y. Grjibovski, Andrej M. Int J Circumpolar Health Original Research Article INTRODUCTION: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The prevalence of hepatitis B (HBV) and C (HCV) in Russia was 7.6 and 5.4 per 100,000, respectively. The aim of this study was to assess the proportion of HCV and HBV infection among HCC patients, to evaluate associations between HCV, HBV and stage of HCC and to compare survival of HCC patients by their HBV/HCV status in the Arkhangelsk region of northwest Russia. MATERIALS AND METHODS: A retrospective cohort study was conducted using data on all histologically confirmed HCC cases. Proportions of infected and non-infected HCC cases were calculated by Wilson's method. The associations between HBV, HCV and severity of HCC were assessed by Pearson's Chi-squared test. Survival data were presented using Kaplan–Meier curves and median survival. Survival time between the groups was compared using log-rank tests. Adjustment for potential confounders (sex, age groups, stage of HCC and cirrhosis stage by Child-Paquet scale) was performed using Cox regression. RESULTS: There were 583 histologically confirmed HCC cases. The viral status was registered in 311 of patients with pre-mortem diagnosis, where 124 or 39.9% (95% confidence interval (CI), 34.4–45.4) had HBV, 54 or 17.4% (95% CI, 13.5–21.9) had HCV and 16 or 5.1% (95% CI, 3.2–8.2) were infected with both HBV and HCV. The median survival rates of patients were 3 months (95% CI, 2.3–3.8), 3 months (95% CI, 2.0–3.9) and 1 month (95% CI, 0.0–0.6) for patients with HBV, HCV and HBV and HCV, respectively. For virus-free patients, it was 5 months (95% CI, 3.5–6.5), log-rank test=10.74, df=3, p=0.013. Crude Cox regression showed increased risk of death for HBV and HBV and HCV groups in comparison with virus-free patients, and not reaching the level of statistical significance for HCV. After adjustment, the hazard ratios (HRs) decreased to non-significant levels or even reversed, with only exception for the group of patients infected with both hepatitis viruses. CONCLUSIONS: We found that more than half of HCC patients were infected with HBV or HCV. The study did not reveal an association between viral status of HCC patients and stage of HCC. The viral hepatitis may have an impact on survival of HCC patients. Co-Action Publishing 2013-05-13 /pmc/articles/PMC3654160/ /pubmed/23687637 http://dx.doi.org/10.3402/ijch.v72i0.20282 Text en © 2013 Maria Makarova et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Makarova, Maria
Krettek, Alexandra
Valkov, Mikhail Y.
Grjibovski, Andrej M.
Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
title Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
title_full Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
title_fullStr Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
title_full_unstemmed Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
title_short Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
title_sort hepatitis b and c viruses and survival from hepatocellular carcinoma in the arkhangelsk region: a russian registry-based study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654160/
https://www.ncbi.nlm.nih.gov/pubmed/23687637
http://dx.doi.org/10.3402/ijch.v72i0.20282
work_keys_str_mv AT makarovamaria hepatitisbandcvirusesandsurvivalfromhepatocellularcarcinomainthearkhangelskregionarussianregistrybasedstudy
AT krettekalexandra hepatitisbandcvirusesandsurvivalfromhepatocellularcarcinomainthearkhangelskregionarussianregistrybasedstudy
AT valkovmikhaily hepatitisbandcvirusesandsurvivalfromhepatocellularcarcinomainthearkhangelskregionarussianregistrybasedstudy
AT grjibovskiandrejm hepatitisbandcvirusesandsurvivalfromhepatocellularcarcinomainthearkhangelskregionarussianregistrybasedstudy